and greatest decrease (4.14 ± 1.32 pmolIL). We argue in favor of the age-and gender-specific central 0.95 intervals obtained for the 182 subjects before being supplemented with folic acid: 4.6-8.1 g.tmol/L for subjects at <30 years; 4.5-7.9
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and greatest decrease (4.14 ± 1.32 pmolIL). We argue in favor of the age-and gender-specific central 0.95 intervals obtained for the 182 subjects before being supplemented with folic acid: 4.6-8. 1 g.tmol/L for subjects at <30 years; 4.5-7. 9 .tmol/L for women, ages 30-59 years; 6.3-11.2 moVL for men, ages 30-59 years; and 5.8-11.9 pmol/L for subjects at >60 years. evidence that a slightly increased concentration of total homocysteine in plasma is a significant independent risk factor for atherosclerotic diseases [1] [2] [3] . Furthermore, measurements of total homocysteine and methylmalonic acid combined improve the rate of detecting cobalamin deficiency over that of methylmalonic acid measurements alone [4] .
So far, several useful methods, e.g., detection by HPLC or stable-isotope-dilution [5] or immunoassay techniques [6] have been developed for the routine determination of homocysteine in plasma. A reliable stable-isotope-dilution technique is widely used for routine determinations of methylmalonic acid in plasma [7] . Recently, a capillary electrophoresis assay for analysis of methylmalonic acid in plasma has been described [8] . Furthermore, adding fluoride to blood samples has recently solved the drawback that, after sampling, blood cells still produce and release homocysteine into the plasma, causing an artificial increase in measured concentrations of 10%/h [9] . [16] introduced the term "a stable low level" to denote the plasma homocysteine concentrations reached in a population with high folate intakes, and Ubbink et al. [13] have published a reference interval based on a mathematical prediction model extrapolating results from four vitamin-supplemented groups to an unsupplemented general population.
In the present work, we report the results of a vitamin supplementation trial. Our goal was to define the upper reference limit for plasma homocysteine in non-cobalaminand non-folate-deficient subjects. We also examined possible age-and gender-related differences.
We included measurements of methylmalonic acid in plasma in the present investigation to make probable the absence of cobalamin deficiency in our reference population and to obtain the same reference population for homocysteine and methylmalonic acid in plasma for future use in the diagnosis of cobalamin deficiency.
Materials and Methods
Su1jects. Our intention was to recruit -40 subjects in each decade of life from age 20 years to >70 years, evenly distributed between the two sexes. During a period of 4 months, 249 apparently healthy volunteers participated in and completed the study. Of these, 241 participants were recruited from among the employees of the hospital and their acquaintances; 8 of the elderly were recruited from the patient register in a rural general practice.
The volunteers agreed to participate after informed consent, in accordance with the Helsinki Declaration. The study was approved by the local committee of medical ethics.
Study design. Three blood samples were taken at intervals of between 1 and 3 weeks. After the initial blood collection (sample 0), the subjects received one tablet containing 1 mg of cyanocobalamin (Betolvex#{174}; Dumex, Copenhagen, Denmark) two times a day for 1 week; in a few cases, for practical reasons, this was followed by one tablet daily for as long as 14 days until the second blood collection (sample 1) could take place. Likewise, one tablet containing 5 mg of folic acid (Nycomed DAK, Copenhagen, Denmark) was subsequently taken two times a day for 1 week-in a few cases, followed by one tablet daily for as many as 14 days until the last blood collection (sample 2).
Homocysteine was assayed in all three samples, methylmalonic acid in the first two samples. To exclude kidney insufficiency, we measured the creatinine content of sample 0. A questionnaire was filled out by the participants regarding whether daily vitamin supplementation containing folic acid was taken on a regular basis, or whether antiepileptic drugs were taken, or whether the participant had psoriasis.
Specimens. Blood samples were taken from an antecubital vein. Plasma samples for measurements of homocysteine and methylmalonic acid were collected in tubes that contained heparin as an anticoagulant and with sodium fluoride added to a final concentration of 4 g/L blood, according to the procedure described previously [9] . Plasma was separated by centrifugation within 2 h and stored at -20 #{176}C until analyzed.
Assays. Total homocysteine and methylmalonic acid in plasma were measured by stable isotope dilution with solid-phase extraction of the sample [7, 9] . Creatinine in plasma was determined by using an Ektachem 700x RC analyzer. 
SELECTION OF THE STUDY GROUP
Of the 249 participants, 3 had a high probability of cobalamin deficiency in the tissues according to the criteria of Nex#{248} et al.
[18], i.e., methylmalonic acid in plasma >0.45 j.mol/L and a subsequent decrease of >20% after cobalamin supplementation. Five had a statistically outlying concentration of methylmalonic acid in plasma initially (>0.36 j.molIL), compared with the entire set of results but also within their age and gender groups. Furthermore, six subjects had deviant concentrations of homocysteine in the first plasma sample (>19.4 mol/L for women and >20.8 .tmol/L for men); these data were also classified as outliers within their age and gender groups. The data from all 14 subjects were excluded from the subsequent analysis. None of the 14 had an abnormal kidney function estimated by the concentration of creatinine in plasma. Details are summarized in Table 1 .
Of the remaining 235 participants, 126 were women, ages 20-85 years (median 49 years), and 109 were men, ages 20-84 years (median 50 years). Distribution by age and gender groups is shown in Table 2 .
All except one subject had concentrations of creatinine in plasma within the reference interval for healthy subjects, 55-120 j.tmol/L.
One man, age 60 years, had a concentration of creatinine in plasma at 141 mol/L.
In agreement with previous studies [19] , this moderate increase in creatinine did not correlate with any increase in methylmalonic acid in the plasma, and his concentration of homocysteine in plasma was not significantly different from the concentrations of the other men in his age group.
EFFECT OF VITAMIN SUPPLEMENTATION
Interindividual variation before vitamins. Fig. 1 shows that the initial concentrations of methylmalonic acid in plasma for the 235 subjects were approximately normally distributed with a slight positive skewness. The mean value was 0.154 jLmolfL (SD 0.050 imol/L). The central 0.95 interval was 0.08-0.28 .tmolfL, as calculated nonparametrically.
Women older than 60 years had a significantly higher concentration of methylmalonic acid in plasma, by an average of 0.03 7 j.tmol/L, than did the younger women. In contrast, the concentration of methylma- MMA0 and MMA1, concentrations of methylmalonic acid in plasma before and after cyanocobalamin supplementation; HCYQand HCY1, concentrations of total homocysteine in plasma before and after supplementation with cyanocobalamin; HCY2. concentration after supplementation with folic acid.
Data excluded because the concentrations of methylmalonic acid in plasma were consistent with cobalamin deficiency (see text).
0 Data excluded because the initial concentrations of methylmalonic acid in plasma were outliers in the statistical context. lonic acid in men exhibited no significant dependence on age. When age was not considered, however, there was no significant difference between the concentrations in men and women. The mean and SD concentrations for the age and sex groups are shown in Table 2 . Figure 2 shows that the initial concentrations of homocysteine for all 235 subjects did not follow a normal distribution curve but exhibited a marked positive skewness. Fig. 3 shows significant differences in homocysteine concentrations between age groups and between the sexes. The mean and SD concentrations for the age and sex groups are shown in Table 2 . Women between ages 30 and 59 years had lower concentrations than men at those ages, and for both sexes the homocysteine concentrations increased significantly with age. For all 235 subjects the mean (± SD) of the initial total homocysteine in Methylmalonic Acid in Plasma (j.tmol/L) (Fig. 1) . However, there was a significant tendency of larger decreases in methylmalonic acid when initial concentrations were >0.24 moVL. Supplementation with cyanocobalamin also caused a small but statistically significant decrease (0.44 ± 1.32 .tmoVL, mean ± SD) in the concentrations of homocysteine in plasma (Fig. 2) . The decrease correlated positively with the initial concentration of homocysteine and with the decrease in methylmalonic acid (P = 0.02). The distribution of homocysteine in plasma after cyanocobalamin administration was positively skewed, like the initial concentrations, and the mean (SD) concentration then was 8.79 ± 2.54 j.LmoVL.
Effect of folic acid supplementation. .tmol/L for men). As with the initial concentrations, women between ages 30 and 59 years had lower concentrations than men of those ages; for both sexes, the groups >60 years had the highest concentrations (see Fig. 3 ). [7, 9] . Although the present study provides no data on intraindividual variations, it is well documented that the intraindividual variation of the concentration of methylmalonic acid in plasma is negligible [20] . In contrast, data on intraindividual variations of the concentrations of homocysteine in plasma are still sparse and inconsistent [5] . 
INTAKE
The 0.95 reference interval for methylmalonic acid concentrations before intake of vitamins (0.08-0.28 p.mol/L) was narrower than the 0.05-0.37 moVL we reported previously [20] , but the selections of the study group in the two studies were not completely comparable. Our present finding is closer to the interval 0.06-0.25 mol/L reported by Naurath et al. [12] . Our results provide the first evidence that women >60 years have higher concentrations of methylmalonic acid in plasma than do younger women.
The 0.95 reference interval for homocysteine concentrations before intake of vitamins (5.5-15.7 j.imol/L) was broader and had a higher mean value than the 4.6-12.3 mol/L interval we observed in an earlier study [9] . The difference is due to a different selection of subjects, the earlier results being based on a much younger study group. Our finding that, in general, men have higher concentrations than women (Fig. 3 ) is in agreement with an earlier report from our laboratory [21] . The finding that women >60 years have higher concentrations than younger women (see Fig. 3 ) has been reported previously by Andersson et al.
[22] and may be related to menopausal status. In general, the concentration of total homocysteine is dependent on both age and gender. Nutritional status is another important determinant of homocysteine concentrations, as illustrated by our Mmol/L higher, a difference probably related to differences in selection of subjects and sample collection. In their subjects, plasma homocysteine was higher in men than in women and increased with age in both sexes. This adds further support to our own findings. Because the Norwegian study demonstrated a significant increase with cigarette smoking, possibly even narrower reference intervals could be achieved by distinguishing between smokers and nonsmokers.
The distribution curve for the homocysteine concentrations of the entire study group in our investigation became more symmetrical after supplementation with folic acid (Fig. 2) but, in contrast to the prediction of Ubbink et al., a positive skewness was still present. The data shown in Fig. 3 suggested a heterogeneity in the population, and the subsequent analysis of variance combined with Duncan's test identified the four significantly different subgroups of different age and gender specified in Table   3 . The cluster analysis identified both in our study group as a whole and in each subgroup a cluster of subjects who responded strongly to folic acid, indicating that, in general agreement with the findings of Ubbink et al. [13] , one-quarter of our participants was actually deficient in folic acid.
The 
